Copyright: ©Author(s) 2026.
World J Clin Oncol. Jun 24, 2026; 17(6): 120388
Published online Jun 24, 2026. doi: 10.5306/wjco.120388
Published online Jun 24, 2026. doi: 10.5306/wjco.120388
Table 3 Demographics and clinical presentation of gastrointestinal stromal tumor patients based on risk stratification, n (%)
| Low-risk (n = 161) | Intermediate-risk (n = 40) | High-risk (n = 81) | P value | |
| Age at surgery (mean ± SD) | 55.1 ± 12.8 | 50.1 ± 12.5 | 51.4 ± 15.0 | 0.06 |
| Males | 101 (62.7) | 28 (70.0) | 54 (66.7) | 0.63 for all |
| Females | 60 (37.3) | 12 (30.0) | 27 (33.3) | |
| Clinical history | ||||
| Neurofibromatosis | 4 (2.5) | 0 (0.0) | 3 (3.7) | 0.46 |
| A skin disorder | 0 (0.0) | 0 (0.0) | 2 (2.5) | 0.08 |
| Familial GIST | 2 (1.2) | 0 (0.0) | 4 (4.9) | 0.10 |
| Clinical presentation | ||||
| Abdominal pain | 106 (65.8) | 24 (60.0) | 59 (72.8) | 0.32 |
| Vomiting | 43 (26.7) | 9 (22.5) | 33 (40.7) | 0.04 |
| Blood in stool/vomit | 55 (34.2) | 19 (47.5) | 38 (46.9) | 0.08 |
| Fatigue due to anemia | 37 (23.0) | 11 (27.5) | 12 (14.8) | 0.20 |
| Bowel obstruction | 7 (4.3) | 0 (0.0) | 6 (7.4) | 0.18 |
| Radiological investigations | ||||
| X-ray | 34 (21.1) | 9 (22.5) | 29 (35.8) | 0.04 |
| Ultrasonography | 67 (41.6) | 16 (40.0) | 30 (37.0) | 0.79 |
| Computed tomography | 127 (78.9) | 38 (95.0) | 66 (81.5) | 0.06 |
| Barium study | 5 (3.1) | 7 (17.5) | 8 (9.9) | 0.003 |
| MRI | 54 (33.5) | 11 (27.5) | 24 (29.6) | 0.69 |
| Endoscopy | 95 (59.0) | 22 (55.0) | 53 (65.4) | 0.47 |
| Localized to primary organ site | 98 (60.9) | 35 (87.5) | 49 (60.5) | 0.005 |
| Locally advanced to other GIT structures | 30 (18.6) | 3 (7.5) | 29 (35.8) | 0.001 |
| Distant metastases | 15 (9.3) | 3 (7.5) | 18 (22.2) | 0.01 |
| Primary location | ||||
| Stomach | 103 (64.0) | 28 (70.0) | 60 (74.1) | 0.26 |
| Duodenum | 10 (6.2) | 1 (2.5) | 4 (4.9) | 0.63 |
| Small bowel | 33 (20.5) | 13 (32.5) | 14 (17.3) | 0.14 |
| Colon | 4 (2.5) | 0 (0.0) | 0 (0.0) | 0.21 |
| Rectum | 6 (3.7) | 0 (0.0) | 2 (2.5) | 0.43 |
| Esophagus | 3 (1.9) | 0 (0.0) | 0 (0.0) | 0.32 |
| Omentum | 0 (0.0) | 2 (5.0) | 4 (4.9) | 0.08 |
| Other sites | 8 (5.0) | 0 (0.0) | 6 (7.4) | 0.21 |
| Histological type | ||||
| Spindle cell type | 102 (63.4) | 27 (67.5) | 30 (37.0) | 0.001 for all |
| Epithelioid type | 5 (3.1) | 1 (2.5) | 12 (14.8) | |
| Mixed type | 24 (14.9) | 8 (20.0) | 20 (24.7) | |
| Unspecified | 30 (18.6) | 4 (10.0) | 19 (23.5) | |
| Immuno-histochemistry | ||||
| CD 117 (n = 259) | 114 (75.5) | 31 (83.8) | 62 (87.3) | 0.10 |
| CD 34 (n = 252) | 87 (59.6) | 26 (70.3) | 55 (79.7) | 0.01 |
| SMA (n = 243) | 39 (28.3) | 14 (37.8) | 30 (44.1) | 0.06 |
| S-100 protein (n = 246) | 8 (5.8) | 2 (5.4) | 9 (12.9) | 0.16 |
- Citation: El-Matbouly MA, Al-Thani H, El-Menyar A, Al-Sulaiti M, Asim M, Al Yaseen M, Suliman A, Albahrani A, Al-Bozom I, Tabeb A. Evolving patterns of gastrointestinal stromal tumor presentation, management, and outcome over three decades: A Middle Eastern retrospective study. World J Clin Oncol 2026; 17(6): 120388
- URL: https://www.wjgnet.com/2218-4333/full/v17/i6/120388.htm
- DOI: https://dx.doi.org/10.5306/wjco.120388